A5061280062- Cystic Fibrosis Research Advances
- Allergic Rhinitis and Sensitization
- Neonatal and Maternal Infections
- SARS-CoV-2 and COVID-19 Research
- Parvovirus B19 Infection Studies
- Food Allergy and Anaphylaxis Research
- Renal Transplantation Outcomes and Treatments
- Pediatric health and respiratory diseases
- Dermatological and COVID-19 studies
- Childhood Cancer Survivors' Quality of Life
- Nosocomial Infections in ICU
- Transplantation: Methods and Outcomes
- Pharmaceutical studies and practices
- Autoimmune and Inflammatory Disorders
IRCCS Materno Infantile Burlo Garofolo
2021-2024
Ospedale di Cattinara
2021-2023
Azienda Sanitaria Universitaria Integrata di Trieste
2022
Infants born before 28 weeks are at risk of contracting healthcare-associated infections (HAIs), which could be caused by pathogens residing on contaminated hospital surfaces. In this longitudinal study, we characterized NGS the bacterial composition nasal swabs preterm newborns, time birth and after admission to Neonatal Intensive Care Unit (NICU), comparing it with that environmental wards delivery during hospitalization. We resistome samples too. The results showed microorganisms...
Background: Children with medical complexity need complex assistance, that considerably affects caregivers’ quality of life. They often multiple medications, a consequent relevant risk errors or poor compliance. Galenic (or compounded) drugs are blended in the pharmacy’s laboratory worldwide according to different rules and tailoring patient’s needs. While their use may sometimes simplify these therapies, little is known about parents’ attitude this issue. Aim: This study aimed at...
Immunosuppression management in transplant recipients is a critical component of pharmacotherapy. This becomes particularly crucial when patients are exposed to multiple medications that may lead pharmacological interactions, potentially compromising the effectiveness immunosuppression. We present case 46-year-old patient diagnosed with cystic fibrosis childhood at our hospital, who underwent bilateral lung transplantation and undergoing immunosuppressive therapy. The was hospitalized due an...
Background. Allergic patients may develop reactions following COVID-19 vaccination more frequently than non-allergic individuals. The aim of our study was to assess the risk in high-risk allergic vaccinated for at University Health Agency Giuliano-Isontina (ASUGI) Trieste (northeastern Italy). Methods. Patients were considered high case of: prior anaphylactic reaction any drug/vaccine; multiple drug allergy; intolerance polyethylene glycol (PEG) or polysorbate 80 (PS80) containing drugs; and...